EN 中文 DE FR عربى

Synlait Sells Assets to Abbott for $307 Million to Reduce Debt

New Zealand 25.11.2025
Source: dairynews.today
220 EN 中文 DE FR عربى
Synlait Milk, a significant player in the nutrition and infant formula industry, has finalized the sale of its North Island assets, including the Pōkeno manufacturing facility, to Abbott Laboratories for about NZ$307 million (US$178 million).
Synlait Sells Assets to Abbott for $307 Million to Reduce Debt

This transaction is supported by Bright Dairy Holding, which holds a 65.25% stake in Synlait, ensuring shareholder approval.

The asset sale is primarily aimed at reducing Synlait's debt, which stood at around NZ$250.7 million. The proceeds are expected to eliminate the company's term debt by the targeted completion date of April 1, 2026. Despite reporting a full-year loss of $39.8 million due to past manufacturing issues, this move strategically positions Synlait for future growth.

Beyond financial stabilization, Synlait is shifting its focus to its South Island facilities, emphasizing high-value nutritional products over large-scale commodity processing. This strategic pivot is part of an 'orderly transition' as Synlait's key customer, The a2 Milk Company, diversifies its supply chain.


Key News of the Week
Calendar